MicrobiologyEmerging Microbes & InfectionsPeer-reviewed
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
S. Schloer, L. Brunotte, J. Goretzko…·U. Rescher
This study identifies fluoxetine and other FIASMAs as inhibitors of SARS-CoV-2 entry by targeting endolysosomal acidification and cholesterol accumulation.
DOI 10.1080/22221751.2020.1829082